Question 1

Does HighTower Advisors own IMVT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, HighTower Advisors holds 56,104 shares of IMVT (Immunovant), worth $2.2M.

Question 2

How many shares of IMVT does HighTower Advisors own?

Accepted Answer

As of its Q2 2026 13F, HighTower Advisors holds 56,104 shares of IMVT (Immunovant).

Question 3

What is HighTower Advisors' IMVT position worth?

Accepted Answer

As of its Q2 2026 13F, HighTower Advisors' IMVT position is worth $2.2M.

Question 4

Is HighTower Advisors buying or selling IMVT?

Accepted Answer

In Q2 2026, HighTower Advisors reduced its IMVT position by 640 shares (-1.1%).

Question 5

When did HighTower Advisors first buy IMVT?

Accepted Answer

HighTower Advisors first reported IMVT in its Q4 2020 13F and has listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	56,104	-1.1%	$2.2M	0.0%	$38.53	0
2026-Q1	Increased	56,744	+69.8%	$1.4M	0.0%	$26.71	38
2025-Q4	Unchanged	33,408	0.0%	$849,228	0.0%	$25.35	0
2025-Q3	Increased	33,408	+0.1%	$538,535	0.0%	$16.06	24
2025-Q2	Increased	33,392	+0.4%	$534,270	0.0%	$16.10	24
2025-Q1	Increased	33,273	+0.7%	$568,633	0.0%	$18.37	24
2024-Q4	Decreased	33,035	-0.6%	$818,274	0.0%	$23.88	0
2024-Q3	Increased	33,224	+28.0%	$947,000	0.0%	$28.02	31